glp 1 non diabetic GLP-1 use tripled among non-diabetics, reaching $5.8B in 2022 Why are GLP-1 agonists being

Unlike diabetic ketoacidosis, the diagnosis of euglycemic diabetic ketoacidosisis often overlooked because of the absence of hyperglycemia.

Ozempic and other GLP-1 receptor agonists can increase insulin secretion, suppress glucagon release, slow digestion, and more

But another conversation has begun gaining momentum centered on fiber and the gut microbiome.

An increasing number of patients treated with novel antidiabetic drugs, including glucagon-like-peptide-1 receptor agonists (GLP-1RA), dual glucose-dependent insulinotropic polypeptide receptor agonists and sodium-glucose cotransporter-2 (SGLT2) inhibitors, are presenting in the perioperative...

Try the Non-Injection GLP-1 Pill Today!

Reaching wider audiences through exciting partnerships